Associate Professor, Pediatrics, University of Minnesota Medical School
Pediatric Pulmonology
Dr. Warren E. Regelmann, MD
|
|
Give Review
Warren Regelmann practices Pediatric Pulmonology. He studied medicine at State University of New York Downstate Medical Center College of Medicine. He has 1 awards "Fellow (FAAP)". Warren Regelmann is a published doctor. He has 57 papers published. The most current publication "Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis."
Publications
- Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with Cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-ar...
- Antibiotic treatment of signs and symptoms of pulmonary exacerbations: A comparison by care site.
- Vitamin D Deficiency Is Associated with Pulmonary Exacerbations in Children with Cystic Fibrosis.
- Insulin secretion improves in Cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
- Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in Cystic fibrosis.
- Pulmonary exacerbations in Cystic fibrosis: young children with characteristic signs and symptoms.
- Glycemic response to dietary supplements in Cystic fibrosis is dependent on the carbohydrate content of the formula.
- Human immunodeficiency virus infections in children. Perspectives for Minnesota.
- Aerosolized recombinant human DNase in hospitalized Cystic fibrosis patients with acute pulmonary exacerbations.
- Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with Cystic fibrosis.
- A pre-post retrospective study of patients with Cystic fibrosis and gastrostomy tubes.
- Oral glucose tolerance testing in children with Cystic fibrosis.
- Sputum desmosine during hospital admission for pulmonary exacerbation in Cystic fibrosis.
- Longitudinal assessment of lung function from infancy to childhood in patients with Cystic fibrosis.
- The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in Cystic fibrosis.
- Oral manifestations of a possible new periodic fever syndrome.
- Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with Cystic fibrosis.
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from Cystic fibrosis patients is associated with lower lung function.
- Staphylococcal alpha-toxin causes increased tracheal epithelial permeability.
- Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage ...
- A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?
- Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in Cystic fibrosis.
- Pulmonary exacerbations in Cystic fibrosis.
- A phase I randomized, multicenter trial of CPX in adult subjects with mild Cystic fibrosis.
- Clinical significance of the recovery of Aspergillus species from the respiratory secretions of Cystic fibrosis patients.
- Epidemiologic study of Cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with Cystic fibrosis in the U.S. and C...
- Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with Cystic fibrosis.
- Proteinase-free myeloperoxidase increases airway epithelial permeability in a whole trachea model.
- PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.
- Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig.
- Prognostic implications of initial oropharyngeal bacterial flora in patients with Cystic fibrosis diagnosed before the age of two years.
- Comparison of Tc-99m DTPA aerosol ventilation studies with pulmonary function testing in Cystic fibrosis.
- Resolution of severe intrapulmonary shunting after liver transplantation.
- Diagnosing the cause of recurrent and persistent pneumonia in children.
- Sputum peroxidase activity correlates with the severity of lung disease in Cystic fibrosis.
- Delivery of oxygen to children with lower respiratory tract infection.
- Recurrent infection in the child.
- Characterization of the human cellular immune response to purified group A streptococcal blastogen A1.
- Functional alterations in non-T cells in rheumatic heart disease.
- Growth in patients with chronic granulomatous disease.
- Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response.
- Compartmentalization of cells bearing "rheumatic" cell surface antigens in peripheral blood and tonsils in rheumatic heart disease.
- Increased monocyte chemiluminescence in Cystic fibrosis patients and in their parents.
- Aerosol penetration ratio: a new index of ventilation.
- Cell surface markers and cellular immune response associated with rheumatic heart disease: complex segregation analysis.
- Interference with granulocyte function by Staphylococcus epidermidis slime.
- Augmentation of cytotoxic activity by mitogens in rheumatic heart disease.
- Lymphocyte subpopulations in rheumatic heart disease.
- Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus.
- Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells.
- Distribution of cells bearing "rheumatic" antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease.
- Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in Cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
- The association of pauciarticular juvenile arthritis and myasthenia gravis.
- Pseudomonas aeruginosa variants isolated from patients with Cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes.
- Increased monocyte oxidase activity in Cystic fibrosis heterozygotes and homozygotes.
- Aerosol scintigraphy in the assessment of therapy for Cystic fibrosis.
Schools
Suny Downstate Medical Center
Minn
University Minn
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Asthma
- Cystic Fibrosis
- Sleep Apnea
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Pulmonology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Humana
- Medica
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- Fellow (FAAP)
Education
-
University of Minnesota at Fairview -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Helpful Reviews
Similar Doctors
|
|
Dr. Michael P. Pryor, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. McNamara, MD |
|
|
Dr. Tamara C. Pozos, MD |
|
|
Dr. Christina L. Mikesell, DO |
|
|
Dr. Gail M. Brottman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiran K. Belani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nadir Demirel, MD |
|
|
Dr. Michael R. Shreve, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Schleiss, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard D. Andersen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theresa A. Laguna, MD |
|
|
Dr. Warren J. Warwick, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Laura G. Hoyt, MD |
|
|
Dr. Chandy C. John, MD |
|
|
Dr. Michelle L. Hulse, MD
This Doctor is OpenDoctor Recommended.
|